Pulmonx Corporation

NASDAQ:LUNG

8.4 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -60.843-58.923-48.661-32.231-20.703-18.479
Depreciation & Amortization 1.9481.5130.8670.4830.3650.27
Deferred Income Tax 0.0240.0491.256-2.760.7460.936
Stock Based Compensation 22.10116.44510.533.1970.3640.366
Change In Working Capital -2.558-7.014-7.846-4.787-2.401-1.523
Accounts Receivables -3.104-2.19-2.4321.457-2.524-0.262
Inventory 0.918-3.638-6.458-5.047-2.613-1.245
Accounts Payables -0.3450.2470.0870.5920.524-0.648
Other Working Capital -0.027-1.4330.957-1.7892.2120.632
Other Non Cash Items 1.7182.8472.4665.4650.8640.036
Operating Cash Flow -37.61-45.083-41.388-30.633-20.765-18.394
Investing Activities:
Investments In Property Plant And Equipment -0.807-1.318-3.671-0.911-0.72-0.316
Acquisitions Net 1.22.90742.584013.5130.016
Purchases Of Investments -46.2-47.187-52.5840-21.450
Sales Maturities Of Investments 4544.281013.6057.9370.5
Other Investing Activites -1.2-2.907-42.58413.605-13.5130.016
Investing Cash Flow -2.007-4.225-46.25512.694-14.2330.2
Financing Activities:
Debt Repayment -19.906-0.0870-19.914-6-12
Common Stock Issued 1.4942.5864.523201.39240.1990.114
Common Stock Repurchased 1.184-0.027-0.026-0.021-0.0120
Dividends Paid 000000
Other Financing Activities 1.494-0.0534.45653.39557.61912.114
Financing Cash Flow 21.42.4724.456234.83145.61912.114
Other Information:
Effect Of Forex Changes On Cash 0.0340.1450.1060.1330.0220.154
Net Change In Cash -18.183-46.744-83.081217.02510.643-5.926
Cash At End Of Period 83.784101.967148.711231.79214.7674.124